Obstetrics and Gynecology

1046 soru

Soru 481Soru →

A 32-year-old primigravid woman at 8 weeks gestation presents to the clinic after noticing a firm, painless lump in her right breast. Examination reveals a 4-cm, hard, immobile mass in the upper outer quadrant with clinically positive axillary lymphadenopathy. She strongly desires to continue the pregnancy and wants to pursue comprehensive treatment to maximize her survival. Assuming the diagnostic workup ultimately confirms invasive ductal carcinoma, arrange the following management steps in the strictly indicated chronological order for this specific patient, from initial evaluation through to postpartum care.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Targeted ultrasound, 2) Core needle biopsy, 3) Mastectomy, 4) Chemotherapy, 5) Radiotherapy.
The sequence reflects the mandatory safety constraints of pregnancy. The workup begins with ultrasound (safest imaging) followed by core biopsy (required for diagnosis). Because the patient is only at 8 weeks gestation (first trimester), chemotherapy cannot be given yet. Therefore, surgery (which is safe under general anesthesia in all trimesters) must precede chemotherapy. Chemotherapy is then initiated once the second trimester is reached. Finally, radiation therapy is absolutely contraindicated at all stages of pregnancy and must be placed last, in the postpartum period.

Adım Adım Çözüm

1
Determine the initial imaging modality.
Targeted ultrasound.
In pregnant women of any age, ultrasound is the preferred initial imaging test for palpable breast masses to eliminate fetal radiation risk.
2
Establish a tissue diagnosis.
Core needle biopsy.
Imaging alone is insufficient to diagnose malignancy; core biopsy under local anesthesia is safe and strictly required before definitive treatment.
3
Select the safest initial definitive therapy for a first-trimester patient.
Mastectomy with axillary staging.
At 8 weeks gestation, chemotherapy is highly teratogenic. Surgery is the only safe major therapeutic intervention in the first trimester. Mastectomy is often chosen because breast-conserving therapy would require radiation, which cannot be safely delivered or delayed for 7+ months.
4
Determine the timing of systemic therapy.
Anthracycline-based chemotherapy in the second trimester.
Chemotherapy can be safely administered during the second and third trimesters, making it the next logical step after the patient recovers from surgery and enters the second trimester.
5
Determine the timing of radiation therapy.
Adjuvant radiotherapy postpartum.
Therapeutic radiation poses severe risks of fetal anomalies and childhood cancer regardless of trimester; thus, it is universally delayed until after delivery.

Anahtar Kavram

The management of breast cancer during pregnancy requires strict adherence to trimester-based contraindications: ultrasound and biopsy are safe anytime, surgery is safe anytime (but is the mandatory first therapeutic step in the 1st trimester), chemotherapy is contraindicated in the 1st trimester but safe in the 2nd/3rd, and radiation is contraindicated until postpartum.
Soru 482Soru →

A 24-year-old woman, gravida 1, para 1, comes to the emergency department 4 weeks postpartum due to a 3-day history of a painful, swollen right breast. She is exclusively breastfeeding her infant. She reports subjective fevers, chills, and fatigue. Her temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 110/70 mmHg110/70\text{ mmHg}, and pulse is 102/min102/\text{min}. Physical examination of the right breast reveals a 4-cm area of marked erythema, induration, and tenderness in the lower outer quadrant. Careful palpation of this area reveals a distinct, centrally fluctuant mass. There is no overlying skin retraction or purulent nipple discharge. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Targeted ultrasound of the right breast

Cevap

Targeted ultrasound of the right breast
The patient's presentation of fever, localized breast erythema, and a fluctuant mass in the setting of lactation is highly suggestive of a breast abscess. The most appropriate next step in management is a targeted ultrasound of the breast. Ultrasound is the imaging modality of choice to confirm the presence of a fluid collection, differentiate it from severe mastitis without an abscess, and directly guide the first-line intervention, which is typically image-guided needle aspiration.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient is a lactating postpartum woman with fever, localized breast erythema, tenderness, and a palpable fluctuant mass.
Identifying these classic signs differentiates complicated mastitis (abscess) from simple lactational mastitis.
2
Determine the primary diagnosis.
The presence of a fluctuant mass in the setting of mastitis strongly suggests a breast abscess.
Fluctuance indicates a localized collection of purulent fluid that requires mechanical intervention.
3
Select the most appropriate next step in management.
Targeted breast ultrasound is indicated.
Ultrasound confirms the presence of an abscess, evaluates its loculations, and provides guidance for first-line treatment, which is minimally invasive needle aspiration.

Anahtar Kavram

Diagnosis and management of lactational breast abscess
Soru 483Soru →

Match each clinical presentation of a breast disorder with its most likely corresponding histopathologic finding on biopsy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 24-year-old woman with a 2-cm mobile, firm, well-circumscribed breast mass; ultrasound demonstrates a homogeneous, solid, hypoechoic oval lesion.
A 48-year-old woman with bilateral, diffuse, tender breast nodularity that fluctuates in severity with her menstrual cycle.
A 36-year-old woman with a firm, localized breast mass and mild skin retraction, developing three months after a motor vehicle collision.
A 31-year-old woman presenting with spontaneous, unilateral bloody nipple discharge without any palpable breast mass or skin changes.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The young woman with a mobile mass matches with stromal proliferation (fibroadenoma); the woman with cyclic nodularity matches with cysts and apocrine metaplasia (fibrocystic changes); the trauma patient matches with anucleated adipocytes and macrophages (fat necrosis); and the patient with bloody discharge matches with fibrovascular cores (intraductal papilloma).
Each clinical scenario correlates precisely with a distinct benign breast pathology's characteristic histopathological appearance. Fibroadenomas feature slit-like spaces; fibrocystic changes feature apocrine metaplasia; fat necrosis features lipid-laden macrophages; and intraductal papillomas feature arborizing fibrovascular cores.

Adım Adım Çözüm

1
Analyze the presentation of the 24-year-old with a mobile, well-circumscribed mass.
Identified as a fibroadenoma.
Mobile, well-circumscribed, solid hypoechoic masses in young women are classic for fibroadenomas, which are characterized histologically by stromal and epithelial proliferation with slit-like spaces.
2
Analyze the presentation of the 48-year-old with cyclic, bilateral nodularity.
Identified as fibrocystic breast changes.
Cyclic breast pain and nodularity in premenopausal women relate to hormonal changes causing cysts, fibrosis, and hallmark apocrine metaplasia.
3
Analyze the presentation of the 36-year-old with a firm mass and skin retraction after trauma.
Identified as fat necrosis.
Blunt trauma to the breast causes adipocyte necrosis, leading to a localized inflammatory response with lipid-laden macrophages, giant cells, and subsequent fibrosis that can mimic malignancy clinically.
4
Analyze the presentation of the 31-year-old with unilateral bloody nipple discharge.
Identified as an intraductal papilloma.
Bloody or serosanguineous nipple discharge without a palpable mass is the hallmark of an intraductal papilloma, characterized by fibrovascular cores proliferating in a dilated duct.

Anahtar Kavram

Clinicopathologic correlation of common benign breast disorders
Soru 484Soru →

Match each clinical presentation with the most likely underlying breast pathology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 21-year-old nulliparous woman presents with a 2-cm, rubbery, highly mobile, non-tender mass in the upper outer quadrant of her left breast.
A 41-year-old woman reports spontaneous, unilateral, bloody nipple discharge. Physical examination reveals no palpable breast masses or axillary lymphadenopathy.
A 49-year-old perimenopausal woman presents with a soft retroareolar mass, mild nipple inversion, and a thick, pasty, greenish-white nipple discharge.
A 36-year-old woman complains of bilateral, diffuse, cord-like breast thickening and pain that begins a week before her period and resolves after menstruation.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations map directly to hallmark benign conditions: the young woman with a mobile mass has a fibroadenoma, the bloody discharge without a mass is an intraductal papilloma, the green discharge with a retroareolar mass is mammary duct ectasia, and the cyclic premenstrual pain represents fibrocystic changes.
Each diagnosis represents a distinct benign breast condition with classic clinical features. Fibroadenomas present as mobile, well-circumscribed masses in young women. Intraductal papillomas present with bloody nipple discharge but no mass. Mammary duct ectasia causes thick, colored discharge and retroareolar masses due to ductal inflammation. Fibrocystic changes cause diffuse, cyclic breast pain and nodularity linked to the menstrual cycle.

Adım Adım Çözüm

1
Evaluate the 21-year-old patient's symptoms.
Identify a solitary, mobile, rubbery mass in a young female, which matches Fibroadenoma.
Fibroadenoma is the most common benign breast tumor in women under 30 and classically presents with these physical examination features.
2
Evaluate the 41-year-old patient's symptoms.
Identify unilateral, bloody discharge without a palpable mass, which matches Intraductal papilloma.
A solitary intraductal papilloma is a benign tumor of the lactiferous ducts and is the leading cause of bloody nipple discharge.
3
Evaluate the 49-year-old patient's symptoms.
Identify a retroareolar mass, nipple inversion, and greenish discharge, which matches Mammary duct ectasia.
Duct ectasia involves chronic inflammation and dilation of the major subareolar ducts, leading to thick colored discharge and sometimes mimicking malignancy (nipple inversion).
4
Evaluate the 36-year-old patient's symptoms.
Identify cyclic, bilateral pain and diffuse nodularity, which matches Fibrocystic changes.
Fibrocystic changes are hormonally mediated, causing diffuse breast lumpiness and pain that worsens before menses and improves afterward.

Anahtar Kavram

Clinical presentation and differentiation of benign breast disorders
Soru 485Soru →

A 42-year-old woman comes to the general surgery clinic for evaluation of a left breast mass that she noticed 3 months ago. She reports that the lump has been growing rapidly during this time. The patient has no personal or family history of breast or ovarian cancer. Physical examination reveals a 5.5-cm, firm, mobile, well-circumscribed mass in the upper outer quadrant of the left breast. The overlying skin appears stretched and shiny with prominent superficial veins, but there is no skin dimpling, nipple retraction, or erythema. Axillary examination shows no palpable lymphadenopathy. Diagnostic mammography and targeted ultrasound demonstrate a large, lobulated, hypoechoic solid mass with internal cleft-like cystic spaces. An image-guided core needle biopsy is performed. Histopathology reveals a cellular fibroepithelial lesion with leaf-like architectural patterns and a hypercellular stroma with moderate atypia, consistent with a borderline phyllodes tumor. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Wide local excision with at least 1-cm margins

Cevap

Wide local excision with at least 1-cm margins
The most appropriate next step in management is wide local excision with at least 1-cm margins. Phyllodes tumors are rare fibroepithelial tumors characterized histologically by leaf-like stromal projections and increased stromal cellularity. Regardless of whether they are classified as benign, borderline, or malignant, the standard of care is complete surgical excision. Because they have a significant propensity for local recurrence, achieving wide negative margins (typically 1 cm or more) is mandatory. Crucially, phyllodes tumors arise from the breast stroma and behave analogously to sarcomas, meaning their primary route of metastasis is hematogenous (most frequently to the lungs) rather than lymphatic. Therefore, routine axillary staging procedures, such as sentinel lymph node biopsy, are not recommended for clinically node-negative patients.

Adım Adım Çözüm

1
Identify the diagnosis from the provided core needle biopsy histopathology.
The presence of a fibroepithelial lesion with a leaf-like architecture and hypercellular stroma confirms a borderline phyllodes tumor.
Accurate pathologic classification is essential to distinguish the mass from a benign fibroadenoma or an invasive adenocarcinoma.
2
Determine the required surgical approach for the primary tumor.
Phyllodes tumors have a high propensity for local recurrence; therefore, they must be excised with wide negative margins of at least 1 cm. Enucleation is contraindicated.
Unlike fibroadenomas, incomplete excision of a phyllodes tumor often leads to aggressive local regrowth.
3
Evaluate the indication for regional axillary lymph node staging.
Sentinel lymph node biopsy or axillary dissection should not be performed.
Phyllodes tumors arise from the breast stroma and behave as sarcomas. Malignant or borderline variants spread hematogenously (typically to the lungs) rather than via the lymphatic system, rendering routine lymphatic staging unnecessary.

Anahtar Kavram

Phyllodes tumors are fibroepithelial breast tumors that require complete surgical resection via wide local excision with at least 1-cm margins. Because they behave like sarcomas and spread hematogenously, routine axillary lymph node staging is not indicated.
Soru 486Soru →

A 35-year-old woman presents to her primary care physician reporting intermittent, reddish-brown discharge from her right nipple over the past 3 weeks. She has noticed small stains on her bra but denies any localized breast pain, overlying skin changes, or fever. Her menstrual cycles are regular, and she takes no daily medications. She has no family history of breast or ovarian cancer. Vital signs are within normal limits. On physical examination, the breasts are symmetric with no skin dimpling, erythema, or nipple retraction. Palpation reveals no discrete masses or axillary lymphadenopathy. Gentle pressure around the right areola elicits a single drop of bloody discharge from a single duct. Which of the following is the most appropriate initial step in the evaluation of this patient?

Cevabı ve açıklamayı göster

Cevap: Mammographic imaging and ultrasonography of the breasts

Cevap

The correct approach is to obtain mammographic imaging and ultrasonography of the breasts.
The correct management is mammographic imaging and ultrasonography of the breasts. This patient's presentation of spontaneous, unilateral, bloody discharge from a single duct is the classic description of pathologic nipple discharge. The most common cause is a benign intraductal papilloma, but underlying malignancies (such as ductal carcinoma in situ or invasive ductal carcinoma) must be excluded. The evaluation of pathologic nipple discharge is age-dependent. In patients under 30 years of age, targeted ultrasound is the first-line imaging modality. In patients 30 years of age and older, bilateral diagnostic mammography and subareolar ultrasonography are both required to adequately assess for masses, microcalcifications, and ductal abnormalities before considering invasive procedures like duct excision.

Adım Adım Çözüm

1
Analyze the characteristics of the patient's presentation.
The patient has unilateral, spontaneous, bloody nipple discharge from a single duct without a palpable mass.
Characterizing the discharge distinguishes between physiologic (endocrine) and pathologic (structural) etiologies.
2
Classify the etiology based on the findings.
The presentation is highly suspicious for a pathologic etiology, with the most common benign cause being an intraductal papilloma, though underlying malignancy must be excluded.
Unilateral, bloody discharge is a classic red-flag sign for structural ductal lesions.
3
Apply age-based diagnostic algorithms for breast pathology.
Because the patient is over 30 years of age (she is 35), she requires both mammography and targeted ultrasound.
Patients <30 undergo targeted ultrasound first to avoid radiation in dense breasts, whereas patients >=30 require both modalities for optimal visualization of calcifications and masses.

Anahtar Kavram

Patients presenting with pathologic nipple discharge (unilateral, spontaneous, bloody, or serous) require prompt diagnostic imaging. Those aged 30 and older should undergo both mammography and ultrasound to evaluate for underlying structural lesions.
Soru 487Soru →

Match each clinical and histopathological description of a breast lesion with its most appropriate definitive management or critical diagnostic association.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old woman undergoes core needle biopsy for architectural distortion. Pathology reveals a monomorphic epithelial proliferation partially filling the involved ducts (atypical ductal hyperplasia).
A 38-year-old woman has a core biopsy of a rapidly enlarging 6-cm mass. Pathology shows a biphasic fibroepithelial proliferation with marked stromal overgrowth, nuclear atypia, and high mitotic activity.
A 52-year-old woman presents with rapid-onset diffuse breast erythema and skin dimpling. A skin punch biopsy demonstrates tumor emboli completely occluding the dermal lymphatic channels.
A 60-year-old woman presents with a unilateral eczematous nipple lesion unresponsive to topical steroids. Biopsy of the nipple epidermis reveals large, atypical cells with abundant pale cytoplasm.
A 50-year-old woman has a core biopsy for grouped microcalcifications. Pathology demonstrates discohesive cells completely filling the lobular acini (classic lobular carcinoma in situ, concordant with imaging).

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Atypical Ductal Hyperplasia requires excisional biopsy. Phyllodes tumor requires wide local excision with >1cm margins. Inflammatory Breast Cancer requires neoadjuvant chemotherapy. Paget disease of the breast requires evaluation for an underlying malignancy. Classic Lobular Carcinoma In Situ is managed with high-risk surveillance and chemoprevention.
Each specific breast pathology has a uniquely tailored management pathway based on its biological behavior. ADH is high-risk for concurrent malignancy and needs excision. Phyllodes tumors recur locally and spread hematogenously, needing wide margins but not axillary staging. IBC is locally advanced and requires upfront systemic therapy. Paget disease is an indicator of deeper malignancy. Classic LCIS is a bilateral risk marker requiring surveillance rather than localized excision.

Adım Adım Çözüm

1
Evaluate the patient with atypical ductal hyperplasia (ADH) on core biopsy.
Match ADH with the need for surgical excisional biopsy.
Core needle biopsy samples only a small portion of the lesion; ADH has a high rate of upstaging to DCIS or invasive carcinoma, so the entire abnormality must be excised for full histologic evaluation.
2
Evaluate the patient with a rapidly enlarging fibroepithelial lesion showing stromal atypia.
Identify as a phyllodes tumor and match with wide local excision (>1 cm margins).
Phyllodes tumors have a high local recurrence rate if excised with positive margins. They spread via hematogenous routes, making axillary staging unnecessary unless nodes are clinically palpable.
3
Evaluate the patient with dermal lymphatic invasion by tumor cells and skin dimpling.
Identify as inflammatory breast cancer (IBC) and match with neoadjuvant chemotherapy.
IBC is an aggressive, locally advanced cancer. Primary surgery is contraindicated due to a high likelihood of positive margins; therapy must begin with systemic chemotherapy.
4
Evaluate the patient with large clear cells in the nipple epidermis.
Identify as Paget disease of the breast and match with the need for comprehensive imaging.
Paget cells represent intraepidermal spread of malignant cells from deeper within the breast parenchyma; the vast majority of these patients have an underlying underlying DCIS or invasive cancer.
5
Evaluate the patient with classic lobular carcinoma in situ (LCIS) that is concordant with imaging.
Match with high-risk surveillance and endocrine risk-reduction therapy.
Unlike DCIS, classic LCIS is a marker of increased risk for developing cancer in either breast. If concordant with imaging, it does not mandate surgical excision.

Anahtar Kavram

Management of high-risk breast lesions and unique breast malignancies requires specific, evidence-based approaches that differ significantly from standard invasive ductal carcinoma.
Tahmini Süre:2m 30s
Soru 488Soru →

A 45-year-old woman presents to the clinic for evaluation of abdominal pain and continuous vaginal discharge. She underwent a total laparoscopic hysterectomy for symptomatic uterine fibroids 14 days ago. Her initial postoperative course was uncomplicated, and she was discharged home on the first postoperative day. Over the past 3 days, she has developed progressive right-sided flank pain, mild nausea, and a continuous, clear, watery vaginal discharge. She reports no dysuria, urgency, or frequency, and she is voiding normally in typical volumes. Her temperature is 38.0°C (100.4°F), blood pressure is 120/78 mm Hg, and pulse is 88/min. Physical examination reveals right costovertebral angle tenderness. The abdomen is soft and non-distended. Speculum examination shows clear fluid pooling in the vaginal vault. A vaginal tampon is placed, and 300 mL of normal saline mixed with methylene blue dye is instilled into the bladder via a Foley catheter. The patient ambulates for 15 minutes, after which the tampon is removed. The tampon is saturated with clear fluid but has no blue staining. Which of the following is the most likely etiology of this patient's current presentation?

Cevabı ve açıklamayı göster

Cevap: Ischemic necrosis of the distal ureter

Cevap

Ischemic necrosis of the distal ureter
The correct answer accurately describes the mechanism of a ureterovaginal fistula. During a total laparoscopic hysterectomy, the distal ureters are highly vulnerable to thermal spread from electrosurgical devices, particularly where they cross under the uterine arteries. This thermal injury does not immediately perforate the ureter; instead, it causes localized ischemia. Over 7 to 14 days, the necrotic tissue sloughs off, creating a fistula tract to the vaginal vault. This explains the delayed onset of the patient's continuous watery vaginal discharge and the right costovertebral angle tenderness (due to preceding stricture and mild hydronephrosis). Crucially, the negative methylene blue test proves the bladder is intact, distinguishing this ureterovaginal fistula from a vesicovaginal fistula.

Adım Adım Çözüm

1
Evaluate the nature of the continuous vaginal discharge.
The continuous, clear, watery fluid pooling in the vaginal vault strongly suggests a urinary tract fistula.
Urine leakage is a classic complication following gynecologic pelvic surgery, presenting as an unremitting clear discharge.
2
Interpret the methylene blue dye test results.
The instilled dye did not stain the tampon, proving the bladder wall is intact.
Methylene blue instilled retrograde into the bladder will leak into the vagina only if a vesicovaginal fistula is present.
3
Localize the source of the clear fluid leakage based on the negative bladder test.
The fluid is urine bypassing the bladder, which localizes the anatomical defect to the ureter (ureterovaginal fistula).
If urine is leaking into the vagina but not originating from the bladder, it must be coming from the ureters, which lie in close proximity to the vaginal vault post-hysterectomy.
4
Determine the pathophysiologic mechanism based on the clinical timeline.
The delayed presentation (14 days post-op) following a laparoscopic procedure points to ischemic necrosis.
Thermal spread from electrocautery during laparoscopy causes vascular compromise. The tissue undergoes gradual necrosis and sloughs off 1 to 2 weeks postoperatively, eventually forming a fistula.

Anahtar Kavram

Ureterovaginal fistula secondary to thermal injury
Tahmini Süre:2m 0s
Soru 489Soru →

A 52-year-old woman undergoes a routine screening mammogram, which reveals a new 1.5-cm spiculated density in the upper outer quadrant of the right breast. She is completely asymptomatic and her past medical history is unremarkable. Arrange the following subsequent steps in her evaluation and management in the most appropriate chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first perform diagnostic imaging, followed by a core needle biopsy, then placement of a radiopaque clip, and finally surgical excision.
The correct chronological sequence for evaluating a suspicious finding on a screening mammogram begins with complete diagnostic imaging. A screening mammogram provides limited views; therefore, diagnostic mammography (e.g., spot compression or magnification views) and targeted breast ultrasound are required to fully characterize the lesion and evaluate the axillary lymph nodes. Once the lesion's suspicious nature is confirmed radiologically, an image-guided core needle biopsy is performed to obtain a definitive tissue diagnosis. Immediately following the biopsy, a radiopaque marker clip is deployed into the biopsy bed. This crucial step ensures the exact site can be localized for future surgical excision, which is especially important if the tumor responds completely to neoadjuvant therapy or if the lesion is non-palpable. Finally, armed with the histologic diagnosis and a marked tumor site, the patient is referred for definitive surgical excision and axillary staging.

Adım Adım Çözüm

1
Perform diagnostic mammography and targeted breast ultrasound
Characterization of the lesion (e.g., BI-RADS 4 or 5) and assessment for multifocal or contralateral disease
Screening mammograms only provide limited standard views. Comprehensive diagnostic imaging is required to fully evaluate the morphology of the mass and the axillary lymph nodes before any invasive procedure.
2
Perform an image-guided core needle biopsy
Procurement of tissue for histologic diagnosis
Tissue sampling is the standard of care for suspicious breast lesions to establish a definitive diagnosis, determine receptor status, and guide multidisciplinary treatment planning.
3
Deploy a radiopaque marker clip into the biopsy bed
Localization of the tumor site
A metallic clip marks the exact location of the biopsied mass. This ensures the site can be found during surgery even if the mass becomes non-palpable or completely resolves radiographically following neoadjuvant chemotherapy.
4
Refer for definitive surgical excision and axillary staging
Tumor resection and pathologic staging
Definitive surgical management (such as lumpectomy with sentinel lymph node biopsy) is performed after the diagnosis is confirmed and the site is securely marked.

Anahtar Kavram

The standard diagnostic workflow for an abnormal screening mammogram involves comprehensive diagnostic imaging, followed by core needle biopsy, radiopaque clip placement to mark the tumor bed, and subsequent definitive surgery.
Tahmini Süre:1m 0s
Soru 490Soru →

A 49-year-old woman is evaluated in the surgical oncology clinic due to rapid changes in her right breast over the past five weeks. She was initially treated at an urgent care clinic with a two-week course of oral clindamycin for presumed cellulitis, but the condition has progressively worsened. She has no personal or family history of breast malignancy and previously had normal screening mammograms. Vital signs are normal. Examination of the right breast reveals diffuse enlargement, marked erythema, and increased warmth. The skin demonstrates prominent pitting edema encompassing most of the breast surface. Palpation reveals diffuse, firm tissue thickening without a discrete localized lump. Hard, enlarged lymph nodes are palpable in the right axillary region.

Arrange the following clinical interventions in the most appropriate chronological order for the diagnosis, staging, and definitive management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of interventions is: 1) Bilateral diagnostic mammography and targeted ultrasonography, 2) Image-guided core needle biopsy of the breast and skin punch biopsy, 3) Systemic staging with cross-sectional imaging and bone scintigraphy, 4) Induction of systemic neoadjuvant chemotherapy, and finally 5) Modified radical mastectomy and axillary lymph node dissection.
The diagnosis and management of inflammatory breast cancer (IBC) require a multidisciplinary approach executed in a specific sequence. When a patient presents with classic signs of IBC (erythema, edema, peau d'orange) that do not respond to antibiotics, the first step is diagnostic imaging (mammography and ultrasound) to evaluate the breast and axilla. This is immediately followed by tissue diagnosis via core needle biopsy of the breast parenchyma and a punch biopsy of the affected skin to confirm dermal lymphatic invasion. Because IBC is inherently a locally advanced disease (Stage IIIB or IIIC) with a high propensity for early metastasis, complete systemic staging (e.g., CT chest/abdomen/pelvis and bone scan) must be performed next. Once distant metastasis is ruled out, the patient must receive systemic neoadjuvant chemotherapy as the initial treatment modality. Upfront surgery is strictly contraindicated due to the high likelihood of positive surgical margins and the need to promptly address micrometastatic spread. Following a clinical response to neoadjuvant chemotherapy, the patient undergoes a modified radical mastectomy (breast-conserving surgery is contraindicated in IBC), typically followed by postmastectomy radiation therapy.

Adım Adım Çözüm

1
Recognize the clinical presentation as highly suspicious for Inflammatory Breast Cancer (IBC).
Identify the need for an urgent oncologic workup rather than further antibiotic therapy.
The patient has progressive breast erythema, edema, and peau d'orange that did not respond to antibiotics, which are classic signs of IBC.
2
Order bilateral diagnostic mammography and targeted ultrasonography.
Evaluate the extent of the local disease and identify regional lymph node involvement.
Imaging is the necessary first step to characterize the breast tissue, assess for underlying masses or calcifications, and guide subsequent biopsy targets.
3
Perform image-guided core needle biopsy of the breast and skin punch biopsy.
Obtain histologic confirmation of invasive carcinoma and dermal lymphatic tumor emboli.
A definitive tissue diagnosis is required before any oncologic therapy can be initiated. A skin punch biopsy specifically evaluates for dermal lymphatic invasion characteristic of IBC.
4
Order systemic staging (CT of the chest, abdomen, pelvis, and bone scan, or PET/CT).
Determine the presence or absence of distant metastatic disease.
IBC is categorized as locally advanced (Stage III) at a minimum and carries a high risk of occult distant metastasis at presentation. Staging must precede treatment because Stage IV disease significantly alters the management goals.
5
Administer neoadjuvant chemotherapy.
Reduce the local tumor burden, clear skin involvement, and treat potential micrometastatic disease.
Upfront systemic therapy is the standard of care for non-metastatic IBC to improve surgical outcomes and overall survival.
6
Perform modified radical mastectomy with axillary lymph node dissection.
Achieve definitive local surgical control.
Breast-conserving therapy (lumpectomy) is contraindicated in IBC due to the diffuse nature of the disease and unacceptably high recurrence rates. Mastectomy follows chemotherapy.

Anahtar Kavram

The diagnostic and management pathway for Inflammatory Breast Cancer follows a strict sequence: Imaging -> Biopsy -> Systemic Staging -> Neoadjuvant Chemotherapy -> Mastectomy -> Postmastectomy Radiation.
Soru 491Soru →

A 46-year-old woman comes to the clinic to discuss the results of a recent breast biopsy. Two weeks ago, a routine screening mammogram revealed a new, 8-mm cluster of pleomorphic microcalcifications in the upper outer quadrant of her right breast. A stereotactic core needle biopsy was performed. The pathology report indicates atypical ductal hyperplasia and fibrocystic changes containing microcalcifications. The patient has no history of breast disease. Menarche was at age 12, and she is nulliparous. Her mother was diagnosed with breast cancer at age 55. Vital signs are within normal limits. Physical examination reveals symmetrical breasts with no palpable masses, skin changes, nipple discharge, or axillary lymphadenopathy. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Needle-localized excisional biopsy

Cevap

The correct answer is needle-localized excisional biopsy.
The correct answer is needle-localized excisional biopsy. Atypical ductal hyperplasia (ADH) is a high-risk breast lesion. When ADH is diagnosed via stereotactic core needle biopsy, it signifies that the needle sampled a high-risk area, but because the needle only removes a small cylinder of tissue, it cannot evaluate the entire lesion. Studies show that 15% to 30% of lesions diagnosed as ADH on core needle biopsy are upgraded to ductal carcinoma in situ (DCIS) or invasive carcinoma when the entire lesion is surgically excised. Therefore, the standard of care requires a needle-localized excisional biopsy to remove the remaining microcalcifications and definitively rule out malignancy.

Adım Adım Çözüm

1
Analyze the patient's presentation and diagnostic findings.
The patient has a stereotactic core needle biopsy of mammographic microcalcifications demonstrating atypical ductal hyperplasia (ADH).
Establishing the specific histological diagnosis is critical for determining the subsequent management algorithm.
2
Determine the clinical significance of the pathology result.
ADH is a high-risk benign lesion. When identified on a core needle biopsy, it carries a 15% to 30% risk of an adjacent, unsampled ductal carcinoma in situ (DCIS) or invasive carcinoma.
Core needle biopsies only sample a small fraction of the targeted lesion, leaving the remainder of the tissue in the breast unexamined.
3
Select the definitive intervention based on the risk of upgrade.
A needle-localized surgical excisional biopsy must be performed to remove the entire area of microcalcifications for complete histological evaluation.
Surgical excision is mandatory to definitively rule out a concurrent malignancy before considering long-term risk reduction strategies like chemoprevention.

Anahtar Kavram

Atypical ductal hyperplasia (ADH) diagnosed on core needle biopsy requires subsequent surgical excisional biopsy to rule out concurrent ductal carcinoma in situ (DCIS) or invasive carcinoma.
Soru 492Soru →

During a routine prenatal visit at 14 weeks gestation, a 34-year-old G2P1 woman mentions a lump in her right breast that she noticed two weeks ago. The patient has no personal or family history of breast cancer. She reports no fever, chills, or nipple discharge. Vital signs are within normal limits. Physical examination reveals a 3-cm, firm, non-tender, and relatively immobile mass in the upper outer quadrant of the right breast. There is no overlying skin erythema, dimpling, or axillary lymphadenopathy. Which of the following is the most appropriate next step in the evaluation of this patient's breast mass?

Cevabı ve açıklamayı göster

Cevap: Targeted breast ultrasound

Cevap

Targeted breast ultrasound
Targeted breast ultrasound is the correct next step because the patient is pregnant. During pregnancy and lactation, breast tissue undergoes physiologic hypertrophy, increasing glandular density. This increased density significantly decreases the sensitivity of mammography. Furthermore, ultrasound safely provides excellent characterization of the mass (differentiating solid from cystic structures) without exposing the fetus to ionizing radiation. If the ultrasound reveals suspicious features, a diagnostic mammogram (with fetal shielding) and a core needle biopsy can be pursued subsequently.

Adım Adım Çözüm

1
Analyze the patient's presentation and demographic profile.
The patient is a 34-year-old pregnant woman (14 weeks gestation) with a newly discovered, firm, non-tender, 3-cm breast mass without signs of infection.
Pregnancy status and the characteristics of the mass guide the diagnostic algorithm.
2
Determine the appropriate initial diagnostic modality.
Targeted breast ultrasound is indicated as the first step.
In pregnant patients (and females <30 years old), breast tissue is dense due to hormonal stimulation, lowering the sensitivity of mammography. Ultrasound safely and accurately differentiates solid masses from fluid-filled cysts.
3
Rule out inappropriate immediate interventions.
Observation, antibiotics, and immediate biopsy are discarded.
The mass is suspicious enough to warrant immediate investigation, lacks infectious features to justify antibiotics, and requires imaging characterization prior to any tissue sampling.

Anahtar Kavram

Evaluation of a palpable breast mass in a pregnant patient
Tahmini Süre:1m 0s
Soru 493Soru →

Match each postoperative clinical presentation with the most likely specific surgical complication or underlying pathophysiology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 42-year-old woman presents with continuous, clear vaginal leakage 10 days after a total laparoscopic hysterectomy. Retrograde instillation of methylene blue into the bladder does not discolor a vaginal tampon, but intravenous indigo carmine administration turns the tampon blue.
A 38-year-old woman develops worsening abdominal distension, ileus, and a rapidly rising serum creatinine level 3 days after a difficult total abdominal hysterectomy for an enlarged, fibroid uterus.
A 32-year-old woman presents to the emergency department with sudden, profuse vaginal bleeding and hemodynamic instability 12 days after undergoing a loop electrosurgical excision procedure (LEEP).
A 45-year-old woman develops sudden-onset confusion, seizures, and respiratory distress with bibasilar crackles immediately following a 90-minute operative transcervical resection of a submucosal leiomyoma.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The scenarios match distinct procedural complications based on diagnostic dye tests, timing of symptom onset, and pathophysiologic mechanisms of injury.
Each clinical scenario requires synthesizing postoperative timing, vital signs, and diagnostic test results to identify the specific anatomical or physiologic complication of common gynecologic surgeries.

Adım Adım Çözüm

1
Analyze the dye test results in the first scenario.
Intravenous indigo carmine stains the tampon, but intravesical methylene blue does not.
This confirms the fluid leakage is originating from the ureter rather than the bladder, establishing the diagnosis of a ureterovaginal fistula.
2
Evaluate the triad of symptoms in the second scenario.
The patient exhibits ascites, ileus, and rising creatinine on postoperative day 3.
This indicates reverse autodialysis of intraperitoneal urine, pointing to an unrecognized bladder dome perforation causing chemical peritonitis.
3
Correlate the timing of bleeding in the third scenario.
Severe bleeding occurs exactly 12 days after a loop electrosurgical excision procedure.
This corresponds directly to the normal timeline of cervical eschar sloughing, a known cause of delayed secondary hemorrhage.
4
Identify the cause of acute neurologic and respiratory symptoms in the fourth scenario.
Immediate postoperative seizures and pulmonary edema follow an operative hysteroscopy.
This indicates massive intravascular absorption of hypotonic distension media, leading to acute hypervolemic hyponatremia (hysteroscopic syndrome).

Anahtar Kavram

Diagnosis of Gynecologic Postoperative Complications
Soru 494Soru →

Match each clinical presentation of early-onset or familial breast cancer with the most likely underlying genetic mutation.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 32-year-old woman with early-onset breast cancer whose family history includes childhood osteosarcoma and adrenocortical carcinoma in first-degree relatives.
A 38-year-old woman with breast cancer who is noted to have macrocephaly on physical examination and a history of surgically treated follicular thyroid carcinoma.
A 45-year-old man diagnosed with invasive ductal carcinoma of the breast whose father recently passed away from pancreatic adenocarcinoma.
A 35-year-old woman with triple-negative breast cancer whose mother and maternal aunt both died of high-grade serous ovarian carcinoma.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The patient with the osteosarcoma and adrenocortical carcinoma family history matches the TP53 mutation (Li-Fraumeni syndrome). The patient with macrocephaly and follicular thyroid carcinoma matches the PTEN mutation (Cowden syndrome). The male patient with a family history of pancreatic cancer matches the BRCA2 mutation. The patient with triple-negative breast cancer and a strong family history of ovarian carcinoma matches the BRCA1 mutation.
Each genetic mutation produces a distinct familial cancer syndrome with characteristic phenotypic features. TP53 mutations cause Li-Fraumeni syndrome (sarcomas, brain tumors, adrenocortical carcinoma). PTEN mutations cause Cowden syndrome (macrocephaly, follicular thyroid cancer, endometrial cancer). BRCA2 is highly associated with male breast cancer and pancreatic cancer. BRCA1 strongly predisposes to triple-negative breast cancer and early-onset ovarian carcinoma.

Adım Adım Çözüm

1
Evaluate the first patient's family history of osteosarcoma and adrenocortical carcinoma.
Identified as classic malignancies associated with Li-Fraumeni syndrome.
To determine the genetic syndrome caused by TP53 mutations.
2
Analyze the second patient's associated findings of macrocephaly and follicular thyroid carcinoma.
Recognized as distinctive phenotypic features of Cowden syndrome.
To link these specific clinical traits to a PTEN mutation.
3
Assess the third patient's male sex and family history of pancreatic cancer.
Correlated specifically with BRCA2 mutations.
BRCA2 has a notably stronger association with male breast cancer and pancreatic cancer compared to other common genetic predispositions.
4
Examine the fourth patient's triple-negative breast cancer and strong ovarian cancer family history.
Linked to a BRCA1 mutation.
BRCA1 is classically associated with triple-negative breast cancers and a high risk of high-grade serous ovarian cancer at a young age.

Anahtar Kavram

Inherited breast cancer syndromes and their associated non-mammary clinical manifestations
Tahmini Süre:1m 30s
Soru 495Soru →

A 34-year-old woman, G2P1, at 18 weeks gestation comes to the physician after discovering a lump in her left breast. She first noticed the lump a month ago and feels it has slightly increased in size. Her medical history is unremarkable, and she has no family history of breast cancer. On physical examination, her breasts are symmetrically enlarged and diffusely nodular. There is a 3-cm, firm, mobile, well-circumscribed, non-tender mass in the left upper outer quadrant. No skin changes, dimpling, or nipple discharge are present. Axillary lymph nodes are not palpable. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Targeted ultrasound of the breast

Cevap

Targeted ultrasound of the breast is the most appropriate next step.
The most appropriate next step in management is a targeted ultrasound of the breast. The evaluation of a palpable breast mass is primarily dictated by the patient's age and physiological state. While diagnostic mammography is the initial imaging modality of choice for non-pregnant women aged 30 and older, pregnancy changes this algorithm. During pregnancy and lactation, the breast undergoes significant glandular hyperplasia and increased water content, resulting in extremely dense breast tissue. This density drastically reduces the sensitivity of mammography. Therefore, targeted ultrasound is the preferred initial imaging test for a palpable mass in all pregnant and lactating women, regardless of age. It provides excellent characterization of the mass (distinguishing solid from cystic lesions) and involves no ionizing radiation exposure to the fetus. If the ultrasound reveals highly suspicious features, a mammogram (with appropriate abdominal shielding) and core needle biopsy can be performed subsequently.

Adım Adım Çözüm

1
Identify the patient's demographic and physiological state.
The patient is a 34-year-old pregnant woman presenting with a new, distinct palpable breast mass.
Pregnancy alters the standard diagnostic algorithms due to physiologic changes in breast tissue and fetal safety considerations.
2
Recall the diagnostic algorithm for palpable breast masses based on age and pregnancy status.
For non-pregnant women 30 years and older, mammography is first-line. However, for women under 30 years OR any pregnant/lactating woman, ultrasound is first-line.
Pregnancy causes glandular hyperplasia, making breasts denser and mammography less sensitive. Ultrasound avoids radiation and effectively distinguishes solid from cystic lesions.
3
Select the most appropriate initial intervention based on the algorithm.
Targeted ultrasound of the breast.
It is the safest and most effective initial imaging modality for evaluating a breast mass during pregnancy.

Anahtar Kavram

In pregnant and lactating women presenting with a palpable breast mass, targeted ultrasound is the initial imaging modality of choice regardless of the patient's age.
Tahmini Süre:1m 15s
Soru 496Soru →

A variety of breast disorders present with distinct clinical, imaging, and historical features that dictate their diagnosis. Match each clinical vignette described below with its most accurate characteristic histopathological finding or pathophysiologic mechanism.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old woman presents with rapid-onset breast erythema, edema, and a 'peau d'orange' appearance; no distinct palpable mass is appreciated.
A 60-year-old woman presents with a persistent, unilateral, eczematous, and scaling plaque on the nipple and areola that has failed to improve with topical corticosteroids.
A 40-year-old woman presents with a firm, irregular breast mass and imaging showing coarse, eggshell calcifications. She reports a history of localized blunt trauma to the area one month prior.
A 35-year-old woman presents with spontaneous, unilateral, bloody nipple discharge. Examination reveals no palpable breast mass or skin changes.
A 25-year-old woman presents with a 2-cm, well-circumscribed, firm, and highly mobile breast mass; ultrasound confirms a solid hypoechoic lesion.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches require correlating the clinical diagnosis from the vignette (Inflammatory breast cancer, Paget disease, Fat necrosis, Intraductal papilloma, and Fibroadenoma) to their respective definitive histopathological mechanisms.
Each clinical vignette is a classic presentation of a specific breast pathology. Matching them correctly requires a two-step diagnostic process: first identifying the disease based on clinical and imaging clues, and then recalling its defining histopathologic or pathophysiologic mechanism.

Adım Adım Çözüm

1
Analyze the presentation of rapid-onset erythema and 'peau d'orange'.
Diagnose inflammatory breast cancer, which corresponds to dermal lymphatic obstruction by tumor cells.
The 'peau d'orange' appearance is a direct result of lymphatic drainage impairment.
2
Evaluate the eczematous nipple lesion failing topical therapy.
Diagnose Paget disease of the breast, which corresponds to the migration of malignant cells into the nipple epidermis.
Steroid-refractory eczema on the nipple should raise immediate suspicion for Paget disease.
3
Identify the post-traumatic firm mass with eggshell calcifications.
Diagnose fat necrosis, corresponding to lipid-laden macrophages and giant cells on pathology.
Trauma leads to adipocyte necrosis, triggering a localized granulomatous inflammatory response.
4
Assess the unilateral bloody nipple discharge without a palpable mass.
Diagnose an intraductal papilloma, corresponding to a benign proliferation over a fibrovascular core.
Papillomas are the most common cause of bloody nipple discharge and are typically small and non-palpable.
5
Evaluate the mobile, well-circumscribed mass in a young woman.
Diagnose a fibroadenoma, corresponding to benign stromal and epithelial proliferation.
Fibroadenomas are the most common benign breast tumors in women under 30 and exhibit biphasic growth.

Anahtar Kavram

Clinical and Histopathological Correlation of Common Benign and Malignant Breast Disorders
Soru 497Soru →

A 27-year-old woman presents to the outpatient clinic with a 3-day history of progressively worsening right-sided breast pain, swelling, and fever. She delivered her first child via uncomplicated cesarean delivery 4 weeks ago and has been exclusively breastfeeding. Her temperature is 38.6°C (101.5°F), blood pressure is 112/72 mmHg, and pulse is 98/min. Physical examination of the right breast reveals a 5-cm area of marked erythema, warmth, and induration in the upper outer quadrant. Careful palpation over this area reveals a distinct, tender, fluctuant mass. There is no overlying skin necrosis, and no axillary lymphadenopathy is appreciated. Pelvic examination is unremarkable, and the cesarean incision site is clean, dry, and well-healed. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Image-guided fluid aspiration and targeted oral antibiotics

Cevap

Image-guided fluid aspiration and targeted oral antibiotics
The patient's presentation of fever, localized breast erythema, and a focal, tender, fluctuant mass in the setting of recent lactation is highly characteristic of a lactational breast abscess. Uncomplicated lactational mastitis generally presents with diffuse induration and erythema but lacks a discrete, fluctuant collection. Once an abscess forms, antibiotic therapy alone is insufficient for resolution because the walled-off cavity prevents adequate drug penetration. The standard of care for a primary lactational breast abscess is drainage (typically via ultrasound-guided needle aspiration, which can be repeated if necessary) combined with targeted oral antibiotics covering Staphylococcus aureus (e.g., dicloxacillin or cephalexin). Continued breastfeeding or pumping should be strongly encouraged to prevent further milk stasis.

Adım Adım Çözüm

1
Identify the patient's primary clinical presentation and physical exam findings.
The patient has localized breast erythema, fever, and a distinct, tender, fluctuant mass 4 weeks postpartum.
Recognizing the timeline and the specific physical exam finding (fluctuance) differentiates simple mastitis from a localized abscess.
2
Formulate a diagnosis based on the physical examination.
The correct diagnosis is a lactational breast abscess.
While uncomplicated mastitis presents with diffuse erythema and induration, the development of a discrete fluctuant mass indicates that a purulent fluid collection (abscess) has formed.
3
Determine the most appropriate management for the diagnosis.
Management requires both source control (drainage) and antimicrobial therapy (antibiotics targeting skin flora).
Antibiotics alone cannot effectively penetrate and resolve a walled-off abscess cavity; physical drainage, typically starting with ultrasound-guided needle aspiration, is required.

Anahtar Kavram

Diagnosis and management of lactational breast abscess
Soru 498Soru →

A 54-year-old postmenopausal woman visits her physician after discovering a firm lump in her right breast. Clinical examination confirms a 2.5-cm, non-tender, relatively fixed mass in the right upper outer quadrant without palpable axillary lymphadenopathy. There is no overlying skin dimpling or nipple retraction. Arrange the following clinical steps in the most appropriate chronological sequence for the standard evaluation and definitive management of this patient's newly discovered breast mass.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for evaluating and managing a palpable breast mass in a woman aged 30 or older begins with diagnostic imaging, followed by a core needle biopsy, molecular characterization of the tumor, primary surgical intervention, and finally adjuvant therapies.
The standard sequence for a new palpable breast mass in a patient older than 30 begins with bilateral diagnostic mammography to evaluate the mass and screen the remainder of the breast tissue. This is followed by an image-guided core needle biopsy for a definitive histologic diagnosis. Once malignancy is confirmed, receptor testing (ER/PR/HER2) is performed on the biopsy specimen to guide treatment. The patient then undergoes definitive surgical management (e.g., lumpectomy with sentinel lymph node biopsy). Finally, adjuvant therapies (radiation, endocrine therapy, chemotherapy) are administered based on the final surgical pathology and receptor status.

Adım Adım Çözüm

1
Perform initial diagnostic imaging.
Characterizes the palpable mass and evaluates the rest of the breast tissue.
Women aged 30 and older with a breast mass require diagnostic mammography and ultrasound before any invasive procedures.
2
Perform core needle biopsy.
Provides a histologic tissue sample.
Solid, suspicious masses require tissue diagnosis to confirm malignancy and differentiate from benign pathology.
3
Test biopsy tissue for hormone and HER2 receptors.
Determines the tumor's molecular subtype.
Receptor status is critical for planning the appropriate multidisciplinary management.
4
Perform surgical resection.
Removes the primary tumor and stages the axilla.
Definitive local control is achieved through surgical excision (lumpectomy or mastectomy) with lymph node evaluation.
5
Administer adjuvant therapy.
Reduces the risk of local and distant recurrence.
Systemic and local adjuvant treatments follow surgery based on tumor characteristics and surgical pathology.

Anahtar Kavram

Diagnostic and management sequence for a palpable breast mass in women aged 30 and older.
Soru 499Soru →

An otherwise healthy 42-year-old patient is evaluated in the outpatient setting for a new-onset, continuous, clear vaginal leakage. Two weeks prior, she underwent a complicated total laparoscopic hysterectomy for severe endometriosis involving dense pelvic adhesions. Her vital signs are within normal limits. A pelvic examination reveals clear fluid pooling in the vaginal vault, while the vaginal cuff appears intact and is healing appropriately. The physician suspects a postoperative urinary tract fistula. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with the retrograde instillation of bladder dye, followed by vaginal inspection to rule out a vesicovaginal fistula, intravenous dye administration to confirm a ureterovaginal fistula, CT urography for anatomic localization, and finally, ureteral stenting for therapeutic management.
The correct sequence follows the standard diagnostic and therapeutic algorithm for a suspected post-hysterectomy urinary fistula. The initial step is to clinically differentiate the source of the fluid. Because vesicovaginal fistulas (VVFs) are the most common, a retrograde dye test (e.g., methylene blue via Foley catheter) is performed first. Inspection of the vagina then verifies if the bladder is intact. If no dye leaks, a VVF is ruled out. Next, intravenous dye (e.g., indigo carmine) is administered; it is filtered by the kidneys and travels down the ureters. If this dye appears in the vagina, a ureterovaginal fistula (UVF) is confirmed. Once clinically diagnosed, cross-sectional imaging (CT urography) is required to delineate the precise location, severity, and any associated complications (like a urinoma). Finally, initial management involves urinary diversion, typically achieved via cystoscopy and retrograde ureteral stenting, which allows the tissue to heal conservatively and reduces inflammation before any delayed surgical intervention is considered.

Adım Adım Çözüm

1
Test for vesicovaginal fistula (VVF) by instilling methylene blue into the bladder.
The bladder is filled with dye, allowing for evaluation of lower urinary tract integrity.
VVF is the most common post-hysterectomy fistula and must be ruled out first.
2
Inspect the vagina for blue dye.
No blue dye is observed in the vagina.
This negative result clinically rules out a VVF, indicating the leak is higher in the urinary tract.
3
Administer IV indigo carmine or oral phenazopyridine.
Dye appears in the vaginal vault.
The dye is excreted via the kidneys into the ureters. Its presence in the vagina confirms a ureterovaginal fistula (UVF).
4
Perform CT urography.
The exact location and severity of the ureteral thermal injury or transection is identified.
Imaging is necessary for surgical planning and to evaluate for associated urinomas or hydronephrosis.
5
Place a retrograde ureteral stent.
Urine is diverted away from the fistula tract.
Stenting promotes conservative healing. If unsuccessful, definitive surgical reimplantation (ureteroneocystostomy) is delayed for 6-12 weeks to allow inflammation to subside.

Anahtar Kavram

The step-wise clinical diagnosis of a postoperative genitourinary fistula involves ruling out a vesicovaginal fistula using retrograde bladder dye before confirming a ureterovaginal fistula with intravenous dye, followed by imaging and ureteral stenting.
Tahmini Süre:2m 0s
Soru 500Soru →

A 45-year-old woman is evaluated in the surgical clinic for a rapidly enlarging mass in her right breast. She first noticed a small lump approximately 4 months ago, but it has doubled in size over the past 4 weeks. She reports no pain, fever, or nipple discharge. Her medical history is unremarkable, and she takes no medications. On physical examination, the breasts appear asymmetric. A 7-cm, firm, smooth, and mobile mass is palpable in the upper half of the right breast. The overlying skin is stretched and shiny with prominent superficial veins, but there is no erythema, dimpling, or nipple retraction. No axillary or supraclavicular lymphadenopathy is appreciated. Breast ultrasonography demonstrates a large, solid, hypoechoic mass with internal cleft-like cystic spaces. A subsequent core needle biopsy reveals a biphasic proliferation consisting of benign epithelial elements and a hypercellular stroma with leaf-like architectural patterns. There are 6 mitoses per 10 high-power fields and moderate stromal atypia. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Surgical removal of the mass with at least 1-cm tumor-free margins

Cevap

Surgical removal of the mass with at least 1-cm tumor-free margins
The correct answer is surgical removal of the mass with at least 1-cm tumor-free margins. This patient's clinical presentation (a rapidly growing, large breast mass) and biopsy findings (biphasic proliferation with a hypercellular stroma and 'leaf-like' architecture) are diagnostic of a phyllodes tumor. The increased mitotic rate (6 per 10 high-power fields) and stromal atypia suggest a borderline or malignant variant. Because phyllodes tumors have a high propensity for local recurrence, standard management for all grades involves complete surgical excision with wide, grossly negative margins (typically at least 1 cm).

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and imaging findings.
A 45-year-old woman presents with a rapidly growing, large (7-cm) breast mass. Imaging shows a solid mass with cystic clefts.
To synthesize the initial clinical picture, which is highly suspicious for a rapidly proliferating neoplasm.
2
Interpret the core needle biopsy results.
The biopsy shows a biphasic tumor with a hypercellular stroma, leaf-like architecture, and increased mitoses.
To establish the definitive diagnosis of a borderline or malignant phyllodes tumor, which is distinctly characterized by these histological features.
3
Determine the appropriate surgical or medical management based on the tumor's biology.
The standard of care is surgical excision with wide margins (at least 1 cm) without routine axillary staging.
Phyllodes tumors have a high risk of local recurrence if not fully excised. However, unlike adenocarcinomas, they spread hematogenously rather than lymphatically, making axillary staging unnecessary.

Anahtar Kavram

Phyllodes tumors are rare, rapidly growing fibroepithelial breast tumors characterized by a leaf-like stromal architecture. The mainstay of treatment is wide local excision with margins of at least 1 cm to prevent recurrence; axillary lymph node staging is generally not required because these tumors spread hematogenously.
Tahmini Süre:1m 30s
ÖncekiSayfa 25 / 53Sonraki
Obstetrics and Gynecology Alıştırma Soruları — USMLE Step 2 CK — Sayfa 25 | Examkin